Search results
Results from the WOW.Com Content Network
The treatment of latent tuberculosis infection (LTBI) is essential to controlling and eliminating TB by reducing the risk that TB infection will progress to disease. Latent tuberculosis will convert to active tuberculosis in 10% of cases (or more in cases of immune compromised patients).
The term "latent tuberculosis treatment" is preferred in the US because the medication does not actually prevent infection: it prevents an existing silent infection from becoming active. The feeling in the US is that the term "treatment of LTBI" promotes wider implementation by convincing people that they are receiving treatment for disease.
Latent TB is treated with either isoniazid or rifampin alone, or a combination of isoniazid with either rifampicin or rifapentine. [140] [141] [142] The treatment takes three to nine months depending on the medications used. [75] [140] [143] [142] People with latent infections are treated to prevent them from progressing to active TB disease ...
Of 200 immigrants tested for tuberculosis over the last year, 8 in 10 had the latent — that's to say, not contagious — version of the disease.
According to a 2013 review, tuberculosis elimination will require not just treating active tuberculosis but also latent cases, and eliminating tuberculosis by 2050 worldwide is not possible, although great reductions in infections and deaths are possible. [3] Addressing poverty is a further requirement for eliminating tuberculosis.
Treatment of latent TB infection typically involves using a single drug for a prolonged period of time—the most common approach is Isoniazid for 9 months. Treatment of active TB disease is typically a combination of antibiotics, which results in patients being non-infectious to others usually within a few weeks.
Treatment requires the use of multiple antibiotics, over a long period of time. [1] Antibiotic resistance is making TB harder to treat, with increasing rates of multiple drug-resistant tuberculosis (called MDR-TB), and extensively drug-resistant tuberculosis (called XDR-TB). [1]
Health department says it is monitoring and working with family of patient “to persuade her to get the treatment she needs.” Tacoma warned of active TB case; TPCHD could seek court order after ...